Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application

Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application

Despite recent advances in the management of ovarian cancer, it remains the most lethal gynecologic malignancy. Vascular endothelial growth factor (VEGF) has been shown to play a pivotal role in the progression of ovarian cancer leading to the eventual development of malignant ascites. On this basis...

Full description

Bibliographic Details
Main Authors:	Afshin Amini, Samar Masoumi Moghaddam, David L. Morris, Mohammad H. Pourgholami
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Journal of Oncology
Online Access:	http://dx.doi.org/10.1155/2012/540791

Similar Items

Initial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines
by: Samar Masoumi Moghaddam, et al.
Published: (2012-01-01)

Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer
by: S. V. Khokhlova
Published: (2014-08-01)

Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
by: Weidemann AK, et al.
Published: (2013-09-01)

Vascular endothelial growth factor as an angiogenic swich in ovarian carcinoma
by: Jyoti Bajpai
Published: (2013-01-01)

Vascular endothelial growth factor and the ovarian response to iatrogenic stimulation
by: McElhinney, B. R.
Published: (2001)

Vascular endothelial growth factor inhibitors for retinopathy of prematurity
by: O.V. Zhukova, et al.
Published: (2020-11-01)

Vascular endothelial growth factor promotes peripheral nerve regeneration after sciatic nerve transection in rat
by: Mohammadi Rahim, et al.
Published: (2013-12-01)

Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders
by: Mansour Homayouni
Published: (2009-04-01)

Effect of treatment with angiopoietin-2 and vascular endothelial growth factor on the quality of xenografted bovine ovarian tissue in mice.
by: Hyun Sun Kong, et al.
Published: (2017-01-01)

Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor.
by: Kanamori, Shuichi
Published: (2014)

Systematic review of the risk of adverse outcomes associated with vascular endothelial growth factor inhibitors for the treatment of cancer.
by: Labib Imran Faruque, et al.
Published: (2014-01-01)

Effect of ovarian steroids on vascular endothelial growth factor a expression in bovine uterine endothelial cells during adenomyosis
by: Martyna Lupicka, et al.
Published: (2019-12-01)

Peptide Inhibitors of Vascular Endothelial Growth Factor A: Current Situation and Perspectives
by: Ivan Guryanov, et al.
Published: (2021-08-01)

The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial Cells.
by: Clare Arnott, et al.
Published: (2016-01-01)

Elevation of vascular endothelial growth factor and distress in ovarian cancer patients: are they correlated? The pilot trial
by: G. P. Guens, et al.
Published: (2016-06-01)

Vascular endothelial growth factor expression in ovarian serous carcinomas and its effect on tumor proliferation
by: Gayatri Ravikumar, et al.
Published: (2013-01-01)

Vascular endothelial growth factor in tumor cells in platinum-containing chemotherapy of advanced ovarian cancer
by: S O Gening, et al.
Published: (2019-07-01)

Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: Basics for Primary Care Providers
by: Carmen P. Escalante, et al.
Published: (2011-01-01)

Aptamer-functionalized gold nanoparticle as a potential vascular endothelial growth factor inhibitor
by: Chen, Chung-Wein, et al.
Published: (2015)

Effects of Hypothyroidism Treatment on the Level of Vascular Endothelial Growth Factor
by: O.M. Didushko
Published: (2015-09-01)

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.
by: Laura Pertl, et al.
Published: (2015-01-01)

Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis
by: Jiahui Zhao, et al.
Published: (2020-03-01)

The Serum Level of Vascular Endothelial Growth Factor (VEGF) is Declined after Paclitaxel-Carboplatin Combined Chemotherapy Treatment on Epithelial Ovarian Cancer
by: Amelia Abdullah
Published: (2012-07-01)

The Serum Level of Vascular Endothelial Growth Factor (VEGF) is Declined after Paclitaxel-Carboplatin Combined Chemotherapy Treatment on Epithelial Ovarian Cancer
by: Amelia Abdullah
Published: (2012-07-01)

The role of vascular endothelial growth factor receptor 3, and its ligands vascular endothelial growth factor C and vascular endothelial growth factor D in tumour metastasis and haematopoeisis
by: Krishnan, Jaya
Published: (2001)

Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor
by: Sarah Waliany, MD, MS, et al.
Published: (2019-09-01)

Effects of intravitreous injection on the expression of vascular endothelial growth inhibitor in vitreous of proliferative diabetic retinopathy
by: Rui Shi, et al.
Published: (2015-06-01)

Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective
by: Siddharth J. Modi, et al.
Published: (2019-06-01)

Effect of Local Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Subcutaneously Allotransplanted Ovarian Tissue in Ovariectomized Mice.
by: Jiangman Gao, et al.
Published: (2015-01-01)

Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population.
by: Bhaskari Janardhan, et al.
Published: (2015-01-01)

Serum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer.
by: Daye Cheng, et al.
Published: (2013-01-01)

Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome
by: Nikita Naredi, et al.
Published: (2013-01-01)

Neopterin as a Stimulator of Vascular Endothelial Growth Factor and Erythropoietin Gene Expression in an Ovarian Carcinoma Cell Line
by: Rieder Josef, et al.
Published: (2005-11-01)

Anti-vascular endothelial growth factor treatment in diabetic macular edema
by: Kim M
Published: (2016-09-01)

Application of anti-vascular endothelial growth factor on the treatment of neovascular glaucoma
by: Ping Wu, et al.
Published: (2015-11-01)

Debate on the various anti-vascular endothelial growth factor drugs
by: Khalili Mohammad, et al.
Published: (2008-01-01)

Angiogenesis and epithelial ovarian cancer : a study of vascular endothelial growth factor (VEGF) and associated factors in the pathogenesis and response to therapy of epithelial ovarian cancer
by: Siddiqui, G.
Published: (2013)

Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies.
by: Parvin Ataie-Kachoie, et al.
Published: (2013-01-01)

Serum and Urine Levels of Vascular Endothelial Growth Factor as Prognostic Markers in Patients with Bladder Cancer
by: Mohsen Ayati, et al.
Published: (2020-04-01)

HEMATOTOXIC ADVERSE DRUG REACTIONS ASSOCIATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS AND CYTOTOXIC DRUGS IN THE TREATMENT OF GLIOBLASTOMA: A SYSTEMATIC REVIEW
by: I. A. Stepanov, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_ol83us8rkv6ji77puajo5tjnp3